Figure 1*. Inhibition of JAK1 and potential targets for developing vitiligo treatments.

CD, cluster of differentiation; CXCL, C-X-C motif chemokine ligand; CXCR, C-X-C motif chemokine
receptor; IFN, interferon; IL, interleukin; IL-R, interleukin receptor; ILC1, group 1 innate lymphoid
cell; JAK, Janus kinase; MMP, matrix metalloproteinase; NK, natural killer cell; ROS, reactive oxygen
species; STAT, signal transducer and activator of transcription; TRM, resident memory T-cell.
*This fi gure was re-created based on the fi gures published in references 6 and 9–18